Patients with a history of epithelial ovarian cancer presenting with a breast and/or axillary mass

Gynecologic Oncology

Volumn 112, Issue 3, 2009, Pages 490-495

  Karam, Amer K ^a   Stempel, Michelle ^a   Barakat, Richard R ^a   Morrow, Monica ^a   Gemignani, Mary L ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Axillary mass; Breast axillary mass; Epithelial ovarian cancer; Ovarian cancer

Indexed keywords

CA 125 ANTIGEN;

ADULT; AGED; ARTICLE; AXILLARY MASS; BREAST CANCER; BREAST TUMOR; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE FREE SURVIVAL; EPITHELIAL OVARIAN CANCER; EPITHELIUM; EXPERIENCE; FAMILY HISTORY; FEMALE; HIGH RISK POPULATION; HUMAN; MAMMOGRAPHY; MEDICAL RECORD REVIEW; OVARY CANCER; OVERALL SURVIVAL; PATHOGENESIS; PRIORITY JOURNAL; SURVIVAL RATE;

ADULT; AGED; BREAST NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; DISEASE-FREE SURVIVAL; EPITHELIAL CELLS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SECOND PRIMARY; OVARIAN NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 60449088699     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2008.11.006     Document Type: Article

References (12)

1. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., et al. Cancer statistics, 2008. CA Cancer J. Clin. 58 2 (2008 (Mar-Apr) 71-96
2. Ozols R.F., Bundy B.N., Greer B.E., Fowler J.M., Clarke-Pearson D., Burger R.A., et al. Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study. J. Clin. Oncol. 21 17 (2003 (Sep 1) 3194-3200
3. Vasey P.A., Jayson G.C., Gordon A., Gabra H., Coleman R., Atkinson R., et al. Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma. J. Natl. Cancer Inst. 96 22 (2004 (Nov 17) 1682-1691
4. Heintz A.P., Odicino F., Maisonneuve P., Quinn M.A., Benedet J.L., Creasman W.T., et al. Carcinoma of the ovary. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. Int. J. Gynaecol. Obstet. 95 Suppl 1 (2006 (Nov) S161-S192
5. Chi D.S., Eisenhauer E.L., Lang J., Huh J., Haddad L., Abu-Rustum N.R., et al. What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?. Gynecol. Oncol. 103 2 (2006 (Nov) 559-564
6. Shah S., Evans D.G., Blair V., Burnell L.D., and Birch J.M. Assessment of relative risk of second primary tumors after ovarian cancer and of the usefulness of double primary cases as a source of material for genetic studies with a cancer registry. Cancer 72 3 (1993 (Aug 1) 819-827
7. Hajdu S.I., and Urban J.A. Cancers metastatic to the breast. Cancer 29 6 (1972 (Jun) 1691-1696
8. McIntosh I.H., Hooper A.A., Millis R.R., and Greening W.P. Metastatic carcinoma within the breast. Clin. Oncol. 2 4 (1976 (Dec) 393-401
9. Alvarado Cabrero I., Carrera Alvarez M., Perez Montiel D., and Tavassoli F.A. Metastases to the breast. Eur. J. Surg. Oncol. 29 10 (2003 (Dec) 854-855
10. Abrams H.L., Spiro R., and Goldstein N. Metastases in carcinoma; analysis of 1000 autopsied cases. Cancer 3 1 (1950 (Jan) 74-85
11. Recine M.A., Deavers M.T., Middleton L.P., Silva E.G., and Malpica A. Serous carcinoma of the ovary and peritoneum with metastases to the breast and axillary lymph nodes: a potential pitfall. Am. J. Surg. Pathol. 28 12 (2004 (Dec) 1646-1651
12. Williams S.A., Ehlers II R.A., Hunt K.K., Yi M., Kuerer H.M., Singletary S.E., et al. Metastases to the breast from nonbreast solid neoplasms: presentation and determinants of survival. Cancer 110 4 (2007 (Aug 15) 731-737